CN103720918A - Traditional Chinese medicine composition for treating jaundice - Google Patents

Traditional Chinese medicine composition for treating jaundice Download PDF

Info

Publication number
CN103720918A
CN103720918A CN201410011224.2A CN201410011224A CN103720918A CN 103720918 A CN103720918 A CN 103720918A CN 201410011224 A CN201410011224 A CN 201410011224A CN 103720918 A CN103720918 A CN 103720918A
Authority
CN
China
Prior art keywords
parts
chinese medicine
medicine composition
jaundice
traditional chinese
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201410011224.2A
Other languages
Chinese (zh)
Other versions
CN103720918B (en
Inventor
冯萍
陈立娥
胡小梅
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201410011224.2A priority Critical patent/CN103720918B/en
Publication of CN103720918A publication Critical patent/CN103720918A/en
Application granted granted Critical
Publication of CN103720918B publication Critical patent/CN103720918B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention relates to a traditional Chinese medicine composition for treating jaundice. The traditional Chinese medicine composition is prepared from the following raw materials in parts by weight: 10-40 parts of dandelion, 20-50 parts of antelope's horn, 30-80 parts of oriental wormwood, 30-80 parts of lycopodium clavatum, 50-120 parts of bee corpses, 20-70 parts of Gekko japonicus, 20-70 parts of agilawood, 20-50 parts of leech, 30-80 parts of silky ant, 30-60 parts of grifola, 1000-3000 parts of live loach and 20-60 parts of crab apple. According to the traditional Chinese medicine composition for treating jaundice, the used raw materials are all natural traditional Chinese medicinal materials, the medicine sources are wide and readily available, the medicines are matched with one another and supplement each other, and the traditional Chinese medicine composition is obvious in curative effect on jaundice and does not have toxic or side effects.

Description

A kind of Chinese medicine composition for the treatment of jaundice
Technical field
The present invention relates to the field of Chinese medicines, be specifically related to a kind of Chinese medicine composition for the treatment of jaundice.
Background technology
Jaundice is common sympton and sign, and it is due to due to bilirubin metabolism obstacle causes in serum that bilirubin concentration raises.Show as clinically sclera, mucosa, skin and hetero-organization thereof and be dyed to yellow.Because sclera contains more elasticin, there is stronger affinity with bilirubin, therefore Patients with Jaundice yellow sclera is often prior to mucosa, skin and first discovered.When serum total bilirubin is at 17.1~34.2 μ mol/L, and naked eyes are not while seeing jaundice, claim latent jaundice or subclinical jaundice; When bloodstain total bilirubin concentration exceedes 34.2 μ mol/L, can find clinically jaundice, also referred to as clinical jaundice.
The reason that jaundice produces mainly contains: bilirubin generates too much; Hepatocyte function is low or have function hepatocyte amount to reduce; It is excessive that hepatocyte is destroyed conjugated bilirubin; Type cholestasis in liver; Blocking etc. of large bile duct.Because the side effect that Chinese medicine composition brings is very little, therefore adopt traditional Chinese medicine composition for treating jaundice very general, but because jaundice is because of many, often therapeutic effect is not obvious.
Summary of the invention
The object of the present invention is to provide that a kind of crude drug source is extensive, evident in efficacy, the Chinese medicine composition of the treatment jaundice that has no side effect.
The technical solution adopted for the present invention to solve the technical problems is: a kind of Chinese medicine composition for the treatment of jaundice, by the raw material of following weight proportioning, made: Herba Taraxaci 10-40 part, Cornu Saigae Tataricae 20-50 part, Herba Artemisiae Scopariae 30-80 part, Lycopodium clavatum 30-80 part, bee corpse 50-120 part, Gekko Swinhonis 20-70 part, Lignum Aquilariae Resinatum 20-70 part, Hirudo 20-50 part, Formica fusca 30-80 part, Polyporus 30-60 part, live loacs 1000-3000 part, crab apple 20-60 part.
Preferably, the Chinese medicine composition of described treatment jaundice is made by the raw material of following weight proportioning: Herba Taraxaci 20-30 part, Cornu Saigae Tataricae 20-40 part, Herba Artemisiae Scopariae 50-60 part, Lycopodium clavatum 50-60 part, bee corpse 80-100 part, Gekko Swinhonis 40-60 part, Lignum Aquilariae Resinatum 40-60 part, Hirudo 20-40 part, Formica fusca 50-60 part, Polyporus 30-50 part, live loacs 1500-2000 part, crab apple 40-60 part.
Preferably, the Chinese medicine composition of described treatment jaundice is made by the raw material of following weight proportioning: 30 parts of Herba Taraxacis, 40 parts of Cornu Saigae Tataricae, 50 parts of Herba Artemisiae Scopariaes, 50 parts of Lycopodium clavatums, 100 parts of bee corpses, 40 parts of Gekko Swinhonis, 40 parts of Lignum Aquilariae Resinatum, 40 parts of Hirudoes, 50 parts of Formica fuscas, 50 parts of Polyporus, 2000 parts of live loacses, 40 parts of crab apples.
First live loacs is put in clear water and supported 1 day, make its emptying enteral refuse, put again next day and in drying baker, dry or dry that to grind bottling into powder standby; Other medicines are dried and are ground to the powder altogether, then mix with Misgurni anguillicaudati powder, and 5g for oral administration, every day 2 times, 30 days was 1 course for the treatment of at every turn.
The pharmacologically active of the each crude drug of the present invention is as follows:
Herba Taraxaci, bitter in the mouth, sweet, cold, returns liver, stomach warp, contains the multiple health-nutrition compositions such as taraxol, taraxacin, choline, organic acid, inulin, has the merit of heat-clearing and toxic substances removing, eliminating carbuncle eliminating stagnation, dampness removing jaundice eliminating, treating stranguria pain relieving.
Cornu Saigae Tataricae, salty in the mouth, cold in nature, returns liver, heart channel, has heat clearing away relieving convulsion, suppressing the hyperactive liver to relieve the wind syndrome, improving acuity of vision and removing nebula, the effect of removing pathogenic heat from blood and toxic substance from the body.
Herba Artemisiae Scopariae, bitter, pungent, be slightly cold, return spleen, stomach, liver, gallbladder meridian, Herba Artemisiae Scopariae clearing away heat-damp and promoting diuresis; Jaundice eliminating, cure mainly jaundice, dysuria, eczema pruritus, infectious jaundice type hepatitis etc., modern pharmacological research confirmation, Herba Artemisiae Scopariae can obviously alleviate Hepatocellular ballooning and downright bad pathological change, and have the effect of repairing hepatocyte structure and recovering its function, thereby reduce serum transaminase vigor.
Lycopodium clavatum, micro-hardship, pungent, temperature, returns liver,spleen,kidney warp, expelling wind and removing dampness, relaxing muscles and tendons and activating QI and blood in the collateral.
Bee corpse, Formica fusca contain the multiple organic acid such as the plurality of inorganic salt close with human serum concentration and vitamin, ferrum, calcium, copper, manganese, potassium, phosphorus, can help patient to supplement the trace element of health.
Gekko Swinhonis, salty, cold, slightly poisonous, dispel the wind, active, eliminating stagnation.
Lignum Aquilariae Resinatum, acrid, bitter, warm, returns spleen, stomach, kidney, lung meridian, and treating the liver is strongly fragrant, falls irritability, and taste, the dampness that disappears, diuretic is had one's ideas straightened out.
Hirudo, salty, bitter, flat, slightly poisonous, return liver, kidney channel.
Polyporus, sweet in the mouth, light, flat, GUIXIN, spleen, stomach, lung, kidney channel, have the diuresis swollen effect of harnessing the river, and containing polyporusum bellatus, test can be anticancer.
Live loacs, sweet in the mouth, property are put down, and return spleen, liver, kidney channel, invigorating spleen and kidney, diuretic, removing toxic substances, also contains abundant nucleoside in Misgurni anguillicaudati body, and nucleoside is the Main Ingredients and Appearance of various vaccines, can improve health anti-virus ability.
Crab apple, sour, sweet, slightly warm in nature, returns spleen, stomach, Liver Channel, and immunity that can enhancing body has the effect of the dissipating blood stasis of having a respite.
The present invention has following beneficial effect: the present invention treats the raw materials used natural Chinese medicine that is of Chinese medicine composition of jaundice, and medicine source is extensively easy to get, and all medicine compatibilities complement each other, and treatment jaundice is evident in efficacy, and has no side effect.
The specific embodiment
Be below specific embodiments of the invention, technical scheme of the present invention is done to further description, but protection scope of the present invention is not limited to these embodiment.Every do not deviate from the change of the present invention design or be equal to substitute include within protection scope of the present invention.
Embodiment 1
Treat a Chinese medicine composition for jaundice, by the raw material of following weight proportioning, made: 10 parts of Herba Taraxacis, 30 parts of Cornu Saigae Tataricae, 60 parts of Herba Artemisiae Scopariaes, 80 parts of Lycopodium clavatums, 50 parts of bee corpses, 50 parts of Gekko Swinhonis, 20 parts of Lignum Aquilariae Resinatum, 30 parts of Hirudoes, 80 parts of Formica fuscas, 60 parts of Polyporus, 1000 parts of live loacses, 60 parts of crab apples.
Embodiment 2
Treat a Chinese medicine composition for jaundice, by the raw material of following weight proportioning, made: 30 parts of Herba Taraxacis, 40 parts of Cornu Saigae Tataricae, 50 parts of Herba Artemisiae Scopariaes, 50 parts of Lycopodium clavatums, 100 parts of bee corpses, 40 parts of Gekko Swinhonis, 40 parts of Lignum Aquilariae Resinatum, 40 parts of Hirudoes, 50 parts of Formica fuscas, 50 parts of Polyporus, 2000 parts of live loacses, 40 parts of crab apples.
Embodiment 3
Treat a Chinese medicine composition for jaundice, by the raw material of following weight proportioning, made: 20 parts of Herba Taraxacis, 50 parts of Cornu Saigae Tataricae, 80 parts of Herba Artemisiae Scopariaes, 30 parts of Lycopodium clavatums, 120 parts of bee corpses, 70 parts of Gekko Swinhonis, 50 parts of Lignum Aquilariae Resinatum, 50 parts of Hirudoes, 30 parts of Formica fuscas, 40 parts of Polyporus, 1000 parts of live loacses, 50 parts of crab apples.
Embodiment 4
Treat a Chinese medicine composition for jaundice, by the raw material of following weight proportioning, made: 30 parts of Herba Taraxacis, 20 parts of Cornu Saigae Tataricae, 30 parts of Herba Artemisiae Scopariaes, 60 parts of Lycopodium clavatums, 70 parts of bee corpses, 20 parts of Gekko Swinhonis, 70 parts of Lignum Aquilariae Resinatum, 20 parts of Hirudoes, 70 parts of Formica fuscas, 30 parts of Polyporus, 3000 parts of live loacses, 20 parts of crab apples.
In the present invention, the using method of compositions is: first live loacs is put in clear water and supported 1 day, make its emptying enteral refuse, put next day again and in drying baker, dry or dry that to grind bottling into powder standby; Other medicines are dried and are ground to the powder altogether, then mix with Misgurni anguillicaudati powder, and 5g for oral administration, every day 2 times, 30 days was 1 course for the treatment of at every turn.
Utilize the Patients with Jaundice clinical treatment observation of Chinese medicine preparation of the present invention to 76 routine different pathogenies, in the course for the treatment of, cure rate reaches 72.4% (curing 55 examples), cure rate 94.7% (curing altogether 71 examples) in two courses for the treatment of, invalid 5 examples, evident in efficacy, cure rate is high, and has no side effect.
Model case:
Case 1: Zhao * *, man, 48 years old, to coerce pain, to examine, card meeting is yellow, spiritlessness and weakness, and with heating, poor appetite, nausea and vomiting, pain that hepatic region is swollen, red tongue, yellow fur, stringy and rolling pulse number.Laboratory checks that leukocyte is often slightly low and normal, and lymphocyte increases relatively.Liver function test serum paddy third turns ammonia apparently higher than normally, is greater than normal peak more than 4 times, B ultrasonic: hepatocyte luminous point increases thick, enhancing change.Be diagnosed as icterohepatitis, controlling should heat-clearing and dampness-resolving.With this side's treatment check afterwards in 15 days, transaminase, liver function indices decline 25-50%; Continue with 15 days, liver and spleen retraction is to normal, and hepatic region is without obvious tenderness and percussion pain, and healing is left hospital.Advise it to avoid the dietary habit such as tobacco and wine, Fructus Capsici, fat meat, keep happy, take a good rest.Follow up a case by regular visits to 2 years without recurrence.
Case 2: what *, female, 35 years old, within one week, feel sick, detest greasy, indigestion and loss of appetite, xerostomia is bitter, weak, yellowish urine is as tea, finds in a couple of days appearance jaundice, health is slightly felt Pruritus, the miserable discomfort of eyes.Through looking into icteric index 60 units, bilirubin >4 milligram %, glutamate pyruvate transaminase 440 is position only, Archon albumen ratio 3.97/4.2S, cholesterol 216.1mg%, HBsAg1:16, is diagnosed as acute jaundice hepatitis B.Take after the course for the treatment of of Chinese medicine composition of the present invention, patient's subjective symptoms disappears, check icteric index 4 units, 0.4 milligram of % of bilirubin, glutamate pyruvate transaminase test recovers normal, albumin, globulin ratio 4.7 3.17, HBsAs the moon turns.Continue to take Chinese medicine composition of the present invention 15 days, liver function is normal, HBsAg feminine gender, and Archon albumen ratio 4.62 3.02, cure.Follow up a case by regular visits to 1 year without recurrence.

Claims (3)

1. a Chinese medicine composition for the treatment of jaundice, is characterized in that, by the raw material of following weight proportioning, is made: Herba Taraxaci 10-40 part, Cornu Saigae Tataricae 20-50 part, Herba Artemisiae Scopariae 30-80 part, Lycopodium clavatum 30-80 part, bee corpse 50-120 part, Gekko Swinhonis 20-70 part, Lignum Aquilariae Resinatum 20-70 part, Hirudo 20-50 part, Formica fusca 30-80 part, Polyporus 30-60 part, live loacs 1000-3000 part, crab apple 20-60 part.
2. the Chinese medicine composition for the treatment of jaundice according to claim 1, is characterized in that, by the raw material of following weight proportioning, is made: Herba Taraxaci 20-30 part, Cornu Saigae Tataricae 20-40 part, Herba Artemisiae Scopariae 50-60 part, Lycopodium clavatum 50-60 part, bee corpse 80-100 part, Gekko Swinhonis 40-60 part, Lignum Aquilariae Resinatum 40-60 part, Hirudo 20-40 part, Formica fusca 50-60 part, Polyporus 30-50 part, live loacs 1500-2000 part, crab apple 40-60 part.
3. the Chinese medicine composition for the treatment of jaundice according to claim 1 and 2, is characterized in that, by the raw material of following weight proportioning, is made: 30 parts of Herba Taraxacis, 40 parts of Cornu Saigae Tataricae, 50 parts of Herba Artemisiae Scopariaes, 50 parts of Lycopodium clavatums, 100 parts of bee corpses, 40 parts of Gekko Swinhonis, 40 parts of Lignum Aquilariae Resinatum, 40 parts of Hirudoes, 50 parts of Formica fuscas, 50 parts of Polyporus, 2000 parts of live loacses, 40 parts of crab apples.
CN201410011224.2A 2014-01-09 2014-01-09 A kind of Chinese medicine composition for the treatment of jaundice Expired - Fee Related CN103720918B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410011224.2A CN103720918B (en) 2014-01-09 2014-01-09 A kind of Chinese medicine composition for the treatment of jaundice

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410011224.2A CN103720918B (en) 2014-01-09 2014-01-09 A kind of Chinese medicine composition for the treatment of jaundice

Publications (2)

Publication Number Publication Date
CN103720918A true CN103720918A (en) 2014-04-16
CN103720918B CN103720918B (en) 2016-04-20

Family

ID=50445380

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410011224.2A Expired - Fee Related CN103720918B (en) 2014-01-09 2014-01-09 A kind of Chinese medicine composition for the treatment of jaundice

Country Status (1)

Country Link
CN (1) CN103720918B (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1197673A (en) * 1998-04-01 1998-11-04 王凤贤 Chinese medicine 'Xiaoyangtang' for curing acute and chronic hepatitis B
CN101757509A (en) * 2009-11-04 2010-06-30 泰一和浦(北京)中医药研究院有限公司 Traditional Chinese medicine composition for treating icterohepatitis and preparation method thereof
CN102068566A (en) * 2009-11-19 2011-05-25 天津中新药业集团股份有限公司乐仁堂制药厂 Quality control method for Yinchen Wudan pills for treating damp-heat jaundice
CN103120732A (en) * 2011-11-18 2013-05-29 北京亚东生物制药有限公司 Chinese medicinal composition for treating jaundice and preparation method thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1197673A (en) * 1998-04-01 1998-11-04 王凤贤 Chinese medicine 'Xiaoyangtang' for curing acute and chronic hepatitis B
CN101757509A (en) * 2009-11-04 2010-06-30 泰一和浦(北京)中医药研究院有限公司 Traditional Chinese medicine composition for treating icterohepatitis and preparation method thereof
CN102068566A (en) * 2009-11-19 2011-05-25 天津中新药业集团股份有限公司乐仁堂制药厂 Quality control method for Yinchen Wudan pills for treating damp-heat jaundice
CN103120732A (en) * 2011-11-18 2013-05-29 北京亚东生物制药有限公司 Chinese medicinal composition for treating jaundice and preparation method thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
唐德江: ""验方治黄疸"", 《医药与保健》, 5 August 1996 (1996-08-05), pages 49 *
闫惠狭等: ""痰瘀兼治法辩治黄疸四则"", 《河南中医》, vol. 28, no. 10, 10 October 2008 (2008-10-10), pages 90 - 92 *

Also Published As

Publication number Publication date
CN103720918B (en) 2016-04-20

Similar Documents

Publication Publication Date Title
CN102327478B (en) Pharmaceutical composition for treating burns and scalds and preparation method thereof
CN104940727A (en) Paste for treating rhinitis and preparation method thereof
CN103720839B (en) Traditional Chinese medicine for treating knee osteoarthritis
CN103041341B (en) Traditional Chinese medicine composition for curing tuberculous exadative pleurisy and preparation method thereof
CN103223131A (en) Liver disease drug
CN103263629B (en) Medical wine and preparation method thereof
CN104548049A (en) Traditional Chinese medicine composition for treating senile osteoporosis and preparation method thereof
CN104524174A (en) Traditional Chinese medicine composition for treating rheumatic arthralgia and preparation method thereof
CN1883679A (en) Medicine for treating pulmonary tuberculosis
CN104474225B (en) Medicine for treating viral myocarditis and preparation method
CN103720918B (en) A kind of Chinese medicine composition for the treatment of jaundice
CN102188643B (en) Medicament for treating damp-heat blockage syndrome and its preparation method
CN101095779A (en) Chinese patent drug for treating diabetes erysipelas
CN104997956A (en) Behcet's syndrome and treatment drug thereof
CN104922290A (en) Medicinal fuse treatment technology for treating rheumatism bone pain
CN103845583B (en) A kind of Chinese medicine preparation and preparation method for the treatment of chronic hepatitis
CN103055299B (en) Traditional Chinese medicine composition for treating slow arrhythmia and preparation method thereof
CN106344763A (en) Composition for treating bone diseases and preparation method thereof
CN102366484A (en) Pharmaceutical composition for treating herpes zoster and preparation method thereof
CN101085312A (en) Traditional Chinese medicine for treating hyperdyroidism
CN105381346A (en) Traditional Chinese medicine for treating proteinuria
CN105920208A (en) Medicinal composition for treating infantile wind-heat type common cold
CN105214065A (en) External chilblain is loose, preparation technology and using method thereof
CN105055864A (en) Traditional Chinese medicine preparation for treating aplastic anemia
CN104689235B (en) A kind of Chinese medicine composition for treating women scapulohumeral periarthritis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20160420

Termination date: 20170109